{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:36:19Z","timestamp":1791426979251,"version":"4.3.3"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":50,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006641","name":"UNICEF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006641","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.coviro.2020.05.005","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T06:31:11Z","timestamp":1593585071000},"page":"68-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination"],"prefix":"10.1016","volume":"41","author":[{"given":"Mark R","family":"Prausnitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L","family":"Goodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A","family":"Rota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter A","family":"Orenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2020.05.005_bib0005","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.49","article-title":"Measles","volume":"2","author":"Rota","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.coviro.2020.05.005_sbref0010","doi-asserted-by":"crossref","first-page":"855","DOI":"10.15585\/mmwr.mm6839a5","article-title":"Progress toward rubella and congenital rubella syndrome control and elimination - worldwide, 2000-2018","volume":"68","author":"Grant","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2020.05.005_sbref0015","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.15585\/mmwr.mm6848a1","article-title":"Progress toward regional measles elimination - worldwide, 2000-2018","volume":"68","author":"Patel","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2020.05.005_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.2.5401.75","article-title":"Frequency of complications of measles, 1963. Report on a national inquiry by the public health laboratory service in collaboration with the society of medical officers of health","volume":"2","author":"Miller","year":"1964","journal-title":"BMJ"},{"key":"10.1016\/j.coviro.2020.05.005_bib0025","series-title":"Handbook of Clinical Neurology, Vol. 123 (3rd series) Neurovirology","first-page":"577","article-title":"Measles virus and the nervous system","author":"Griffin","year":"2014"},{"key":"10.1016\/j.coviro.2020.05.005_bib0030","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/infdis\/137.6.847","article-title":"From the Center for Disease control: current status of measles in the United States, 1973\u20131977","volume":"137","author":"Orenstein","year":"1978","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.coviro.2020.05.005_bib0035","first-page":"S4","article-title":"The clinical significance of measles: a review","volume":"189","author":"Perry","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.05.005_bib0040","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ije\/dyn224","article-title":"Estimates of measles case fatality ratios: a comprehensive review of community-based studies","volume":"38","author":"Wolfson","year":"2009","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.coviro.2020.05.005_bib0045","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/jama.286.5.563","article-title":"Malnutrition, measles, mortality, and the humanitarian response during a famine in Ethiopia","volume":"286","author":"Salama","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.coviro.2020.05.005_bib0050","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1126\/science.aaa3662","article-title":"Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality","volume":"348","author":"Mina","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.coviro.2020.05.005_bib0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07515-0","article-title":"Studies into the mechanism of measles-associated immune suppression during a measles outbreak in the Netherlands","volume":"9","author":"Laksono","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2020.05.005_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030178","article-title":"Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques","volume":"3","author":"de Swart","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.05.005_bib0065","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1126\/science.aay6485","article-title":"Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens","volume":"366","author":"Mina","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.coviro.2020.05.005_bib0070","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aay6125","article-title":"Incomplete genetic reconstitution of B cell pools contributes to prolonged immunosuppression after measles","volume":"4","author":"Petrova","year":"2019","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coviro.2020.05.005_bib0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/oxfordjournals.aje.a115106","article-title":"An explosive point-source measles outbreak in a highly vaccinated population. Modes of transmission and risk factors for disease","volume":"129","author":"Chen","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.coviro.2020.05.005_bib0080","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1542\/peds.75.4.676","article-title":"Measles outbreak in a pediatric practice: airborne transmission in an office setting","volume":"75","author":"Bloch","year":"1985","journal-title":"Pediatrics"},{"key":"10.1016\/j.coviro.2020.05.005_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001263","article-title":"Early target cells of measles virus after aerosol infection of non-human primates","volume":"7","author":"Lemon","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2020.05.005_bib0090","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1128\/JVI.01559-09","article-title":"Measles virus infection of alveolar macrophages and dendritic cells precedes spread to lymphatic organs in transgenic mice expressing human signaling lymphocytic activation molecule (SLAM, CD150)","volume":"84","author":"Ferreira","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.05.005_bib0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.coviro.2012.03.005","article-title":"The pathogenesis of measles","volume":"2","author":"de Vries","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2020.05.005_bib0100","first-page":"1407","article-title":"Outbreak of measles in a highly vaccinated secondary school population","volume":"155","author":"Sutcliffe","year":"1996","journal-title":"CMAJ"},{"key":"10.1016\/j.coviro.2020.05.005_bib0105","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/risa.12637","article-title":"Evolution and use of dynamic transmission models for measles and rubella risk and policy analysis","volume":"36","author":"Thompson","year":"2016","journal-title":"Risk Anal"},{"key":"10.1016\/j.coviro.2020.05.005_bib0110","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1016\/S1473-3099(17)30307-9","article-title":"The basic reproduction number (R0) of measles: a systematic review","volume":"17","author":"Guerra","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coviro.2020.05.005_bib0115","first-page":"61","article-title":"Meeting of the International Task Force for Disease Eradication, November 2015","volume":"91","author":"World Health Organisation","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.coviro.2020.05.005_sbref0120","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1080\/14760584.2017.1393337","article-title":"Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach","volume":"16","author":"Goodson","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.coviro.2020.05.005_bib0125","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.15585\/mmwr.mm6745a2","article-title":"Global routine vaccination coverage - 2017","volume":"67","author":"VanderEnde","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2020.05.005_bib0130","series-title":"Global Vaccine Action Plan 2011-2020","author":"World Health Organisation","year":"2012"},{"issue":"Suppl. 2","key":"10.1016\/j.coviro.2020.05.005_bib0135","doi-asserted-by":"crossref","first-page":"B149","DOI":"10.1016\/j.vaccine.2012.11.091","article-title":"Enabling implementation of the Global Vaccine Action Plan: developing investment cases to achieve targets for measles and rubella prevention","volume":"31","author":"Thompson","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2020.05.005_bib0140","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1473-3099(19)30558-4","article-title":"The public health crisis of underimmunisation: a global plan of action","volume":"20","author":"Gostin","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coviro.2020.05.005_bib0145","doi-asserted-by":"crossref","first-page":"937","DOI":"10.15585\/mmwr.mm6842a1","article-title":"Global routine vaccination coverage, 2018","volume":"68","author":"Peck","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coviro.2020.05.005_bib0150","series-title":"Global Measles and Rubella Strategic Plan 2012-2020","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.coviro.2020.05.005_bib0155","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1016\/j.vaccine.2019.02.058","article-title":"Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey","volume":"37","author":"Kriss","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2020.05.005_bib0160","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1016\/j.vaccine.2019.01.081","article-title":"Accelerating measles and rubella elimination through research and innovation \u2013 findings from the Measles & Rubella Initiative research prioritization process, 2016","volume":"37","author":"Grant","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2020.05.005_bib0165","series-title":"Immunization Agenda 2030 (IA2030)","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.coviro.2020.05.005_bib0170","series-title":"Measles-rubella microarray patch (MR\u2013MAP) target product profile","author":"World Health Organization and The United Nations Children\u2019s Fund","year":"2019"},{"key":"10.1016\/j.coviro.2020.05.005_bib0175","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1016\/j.vaccine.2015.02.074","article-title":"A microneedle patch containing measles vaccine is immunogenic in non-human primates","volume":"33","author":"Edens","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2020.05.005_sbref0180","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/infdis\/jiy139","article-title":"A microneedle patch for measles and rubella vaccination is immunogenic and protective in infant rhesus macaques","volume":"218","author":"Joyce","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2020.05.005_bib0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-chembioeng-060816-101514","article-title":"Engineering microneedle patches for vaccination and drug delivery to skin","volume":"8","author":"Prausnitz","year":"2017","journal-title":"Annu Rev Chem Biomol Eng"},{"key":"10.1016\/j.coviro.2020.05.005_bib0190","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s11095-017-2223-2","article-title":"Dissolving microneedle patches for dermal vaccination","volume":"34","author":"Leone","year":"2017","journal-title":"Pharm Res"},{"key":"10.1016\/j.coviro.2020.05.005_bib0195","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4155\/tde-2017-0032","article-title":"Microneedles for vaccine delivery: challenges and future perspectives","volume":"8","author":"Shin","year":"2017","journal-title":"Ther Deliv"},{"key":"10.1016\/j.coviro.2020.05.005_bib0200","first-page":"379","article-title":"Technology update: dissolvable microneedle patches for vaccine delivery","volume":"12","author":"Rodgers","year":"2019","journal-title":"Med Dev (Auckland, N.Z.)"},{"key":"10.1016\/j.coviro.2020.05.005_bib0205","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1016\/j.vaccine.2019.03.035","article-title":"Potential use of microarray patches for vaccine delivery in low- and middle- income countries","volume":"37","author":"Peyraud","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2020.05.005_bib0210","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1021\/js980042+","article-title":"Microfabricated microneedles: a novel approach to transdermal drug delivery","volume":"87","author":"Henry","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.coviro.2020.05.005_sbref0215","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(17)30575-5","article-title":"The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial","volume":"390","author":"Rouphael","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.coviro.2020.05.005_bib0220","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1016\/j.vaccine.2018.05.053","article-title":"Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch\u2122)","volume":"36","author":"Fernando","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2020.05.005_bib0225","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/jc.2009-0358","article-title":"Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women","volume":"95","author":"Cosman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.coviro.2020.05.005_bib0230","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/0333102417737765","article-title":"Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine","volume":"38","author":"Spierings","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.coviro.2020.05.005_bib0235","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/17425247.2018.1410138","article-title":"Human studies with microneedles for evaluation of their efficacy and safety","volume":"15","author":"Nguyen","year":"2018","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.coviro.2020.05.005_bib0240","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/biol.1997.0103","article-title":"Altenative routes of measles immunization: a review","volume":"25","author":"Cutts","year":"1997","journal-title":"Biologicals"},{"key":"10.1016\/j.coviro.2020.05.005_sbref0245","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1016\/j.vaccine.2012.09.062","article-title":"Measles vaccination using a microneedle patch","volume":"31","author":"Edens","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2020.05.005_bib0250","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/JVI.02924-14","article-title":"Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates","volume":"89","author":"Rennick","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2020.05.005_bib0255","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijpharm.2017.02.011","article-title":"Successful application of large microneedle patches by human volunteers","volume":"521","author":"Ripolin","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.coviro.2020.05.005_bib0260","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/AJP.0b013e31816778f9","article-title":"Effect of microneedle design on pain in human volunteers","volume":"24","author":"Gill","year":"2008","journal-title":"Clin J Pain"},{"key":"10.1016\/j.coviro.2020.05.005_bib0265","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejps.2008.06.016","article-title":"In vivo assessment of safety of microneedle arrays in human skin","volume":"35","author":"Bal","year":"2008","journal-title":"Eur J Pharm Sci."},{"key":"10.1016\/j.coviro.2020.05.005_bib0270","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11095-010-0101-2","article-title":"Microneedles in clinical practice\u2013an exploratory study into the opinions of healthcare professionals and the public","volume":"28","author":"Birchall","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.coviro.2020.05.005_bib0275","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/193229680700100517","article-title":"Does needle size matter?","volume":"1","author":"Gill","year":"2007","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.coviro.2020.05.005_bib0280","series-title":"ISMP National Vaccine Errors Reporting Program 2017 Analysis (Part I):\u2008Vaccine Errors Continue with Little Change","author":"Institute for Safe Medication Practices (ISMP)","year":"2018"},{"key":"10.1016\/j.coviro.2020.05.005_bib0285","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/trstmh\/trx018","article-title":"Time for an immunisation paradigm shift","volume":"111","author":"Durrheim","year":"2017","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.coviro.2020.05.005_bib0290","first-page":"789","article-title":"Unsafe injections in the developing world and transmission of bloodborne pathogens: a review","volume":"77","author":"Simonsen","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.coviro.2020.05.005_bib0295","series-title":"Sharps Injuries: Global Burden of Disease from Sharps Injuries to Health-care Workers","author":"Pruss-Ustun","year":"2003"},{"key":"10.1016\/j.coviro.2020.05.005_bib0300","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-11-425","article-title":"Impact of changing the measles vaccine vial size on Niger\u2019s vaccine supply chain: a computational model","volume":"11","author":"Assi","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.coviro.2020.05.005_bib0305","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.vaccine.2016.11.066","article-title":"Doses per vaccine vial container: an understated and underestimated driver of performance that needs more evidence","volume":"35","author":"Heaton","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2020.05.005_bib0310","series-title":"World Health Organization: Controlled Temperature Chain (CTC)","author":"World Health Organisation","year":"2017"},{"key":"10.1016\/j.coviro.2020.05.005_bib0315","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40268-016-0144-x","article-title":"Assessing the potential cost-effectiveness of microneedle patches in childhood measles vaccination programs: the case for further research and development","volume":"16","author":"Adhikari","year":"2016","journal-title":"Drugs R&D"},{"key":"10.1016\/j.coviro.2020.05.005_bib0320","article-title":"Implementing 5-dose measles-rubella vaccine vials in Zambia","author":"John Snow, Inc","year":"2019","journal-title":"Report"},{"key":"10.1016\/j.coviro.2020.05.005_bib0325","doi-asserted-by":"crossref","first-page":"6793","DOI":"10.1016\/j.vaccine.2017.04.063","article-title":"Challenges of vaccine presentation and delivery: how can we design vaccines to have optimal programmatic impact?","volume":"35","author":"Giersing","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2020.05.005_bib0330","first-page":"561","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, October 2016 - conclusions and recommendations","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.coviro.2020.05.005_sbref0335","series-title":"The PATH Center of Excellence for Microarray Patch Technology","author":"PATH","year":"2019"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625720300262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625720300262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:03:24Z","timestamp":1761818604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625720300262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":67,"alternative-id":["S1879625720300262"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2020.05.005","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2020.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}